Fortrea Holdings Inc. (FTRE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.95B
Last updated: Nov 17, 2026 at 11:06 AM ET
Fortrea Holdings Inc. (FTRE) Competitors
The companies most similar to Fortrea Holdings are Forte Biosciences (FBRX), Structure Therapeutics Inc. American Depositary Shares (GPCR) and Tyra Biosciences (TYRA). By market cap, Fortrea Holdings ranks 7th of the 13 companies on this page; Legend Biotech (LEGN) is the largest at $3.39B.
Peer Comparison
FTRE's ROIC of 1.8% is above the peer median of -29.7%, and its revenue growth of -1.4% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Fortrea Holdings (FTRE) | $1.95B | 26.0x | 0.7x | -2.6% | 1.8% | -1.4% | 0.00% |
| Forte Biosciences Inc (FBRX) | $1.63B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | $1.43B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tyra Biosciences Inc (TYRA) | $1.38B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Trevi Therapeutics Inc (TRVI) | $1.95B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Harmony Biosciences Holdings (HRMY) | $1.98B | 9.6x | 1.9x | 18.0% | 13.7% | 12.3% | 0.00% |
| Biohaven Ltd. (BHVN) | $2.09B | N/A | N/A | 0.0% | -315.9% | 0.0% | 0.00% |
| Vera Therapeutics Inc (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Sarepta Therapeutics Inc (SRPT) | $1.72B | N/A | 0.8x | -5.9% | -3.2% | -4.5% | 0.00% |
| Maravai Lifesciences Holdings Inc (MRVI) | $1.96B | N/A | 5.2x | -30.8% | -28.3% | 10.1% | 0.00% |
| Alpha Tau Medical Ltd (DRTS) | $1.24B | N/A | N/A | 0.0% | -176.9% | 0.0% | 0.00% |
| Peer median | $1.95B | 138.0x | 3.7x | 0.0% | -29.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Fortrea Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Forte Biosciences Inc (FBRX) | Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California. | |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic... | GPCR competitors |
| Tyra Biosciences Inc (TYRA) | Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes... | TYRA competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Trevi Therapeutics Inc (TRVI) | Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious... | TRVI competitors |
| Harmony Biosciences Holdings (HRMY) | Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. | HRMY competitors |
| Biohaven Ltd. (BHVN) | Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders... | BHVN competitors |
| Vera Therapeutics Inc (VERA) | Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases... | VERA competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Sarepta Therapeutics Inc (SRPT) | Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy... | SRPT competitors |
| Maravai Lifesciences Holdings Inc (MRVI) | Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines... | MRVI competitors |
| Alpha Tau Medical Ltd (DRTS) | Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development... | DRTS competitors |
Frequently Asked Questions About FTRE
Who are Fortrea Holdings' main competitors?
The companies most similar to Fortrea Holdings include Forte Biosciences (FBRX), Structure Therapeutics Inc. American Depositary Shares (GPCR), Tyra Biosciences (TYRA), Beam Therapeutics (BEAM) and Trevi Therapeutics (TRVI), listed from the closest match.
Who is Fortrea Holdings' biggest competitor?
Legend Biotech (LEGN) is the largest of the similar companies at $3.39B; Forte Biosciences (FBRX) is the closest match by business profile, size, sector and industry.
How does FTRE stock compare with its competitors?
FTRE's P/E is 26.0x against a peer median of 138.0x; its P/S is 0.7x against a peer median of 3.7x; its net margin is -2.6% against a peer median of 0.0%.
Which of Fortrea Holdings' competitors pays a higher dividend?
Fortrea Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Fortrea Holdings bigger than its competitors?
No. Fortrea Holdings is 7th by market cap among the 13 companies on this page; the largest is Legend Biotech (LEGN) at $3.39B.
FTRE pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors